:

Is metformin anti aging and anticancer benefits? A scientific investigation

Observational studies show that diabetics taking metformin may have a lower risk of developing certain cancers and a reduced mortality rate compared to those not on the medication. These findings have fueled immense interest in the question: is metformin anti aging and anticancer benefits a reality for the general population, or is the evidence more complex? This article dissects the current scientific understanding of metformin's potential beyond diabetes management.